Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol
Abstract Background: Standard medications for opioid used disorder (MOUD) provide effective treatment pathways for recovery compared with no treatment or…